Use of hyaluronidase in plastic surgery: A review
- PMID: 34024740
- DOI: 10.1016/j.bjps.2021.03.125
Use of hyaluronidase in plastic surgery: A review
Abstract
Hyaluronidase is a family of enzymes that degrade hyaluronic acid (HA). It is found to increase vascular permeability and temporarily disrupt the extracellular matrix, promoting diffusion of substances through tissues. Alongside its applications in ophthalmology, obstetrics and gynaecology, musculoskeletal medicine, radiology and drug and fluid administration, hyaluronidase has a number of roles in the field of plastic surgery. The popularity of HA fillers in recent years has led to an increase in the usage of hyaluronidase in the treatment of filler-related complications. The purpose of this article is to review the current and future uses of hyaluronidase within the field of plastic surgery. Hyaluronidase is used as an adjunct to local anaesthetics in skin infiltration, skin graft harvesting, tumescent analgesia, managing complications of dermal fillers, treatment of extravasation injury, prevention and management of oedema, treatment of ganglion and management of scars. However, it has some limitations. Hyaluronidase is known to interact with a number of common medications. Several case reports also highlight the risk of allergic reaction to the substance. Although rare and usually mild, hyaluronidase has the potential to cause anaphylaxis. Other adverse effects include bruising and swelling. Overall, hyaluronidase appears to be a very safe, cheap and effective medication for a variety of uses in the field of plastic surgery and beyond.
Keywords: Hyalase; Hyaluronic Acid; Hyaluronidase; Plastic Surgery.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Delayed allergic hypersensitivity to hyaluronidase during the treatment of granulomatous hyaluronic acid reactions.J Cosmet Dermatol. 2018 Dec;17(6):991-995. doi: 10.1111/jocd.12461. Epub 2017 Nov 21. J Cosmet Dermatol. 2018. PMID: 29159865
-
A national shortage and increasing demand: Dispersing evidence-based use of hyaluronidase in plastic surgery.J Plast Reconstr Aesthet Surg. 2021 Jul;74(7):1633-1701. doi: 10.1016/j.bjps.2020.12.046. Epub 2020 Dec 26. J Plast Reconstr Aesthet Surg. 2021. PMID: 33414094 No abstract available.
-
Conventional High-Dose vs Low-Dose Hyaluronidase for Skin Necrosis after Hyaluronic Acid Fillers: A Systematic Review and Pilot Meta-Analysis.Aesthetic Plast Surg. 2024 Oct;48(19):3971-3978. doi: 10.1007/s00266-024-04334-1. Epub 2024 Aug 30. Aesthetic Plast Surg. 2024. PMID: 39214904
-
The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.Aesthet Surg J. 2013 Nov 1;33(8):1167-74. doi: 10.1177/1090820X13511970. Epub 2013 Nov 6. Aesthet Surg J. 2013. PMID: 24197934 Review.
-
Hyaluronic acid fillers and hyaluronidase use in regional eye blocks.Anaesthesia. 2016 Aug;71(8):988-9. doi: 10.1111/anae.13597. Anaesthesia. 2016. PMID: 27396266 No abstract available.
Cited by
-
Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets.Mol Biomed. 2025 Jul 12;6(1):50. doi: 10.1186/s43556-025-00299-y. Mol Biomed. 2025. PMID: 40646377 Free PMC article. Review.
-
Administration Method and Potential Efficacy of Hyaluronidase for Hyaluronic Acid Filler-Related Vision Loss: A Systematic Review.Aesthetic Plast Surg. 2024 Feb;48(4):709-718. doi: 10.1007/s00266-022-03215-9. Epub 2022 Dec 27. Aesthetic Plast Surg. 2024. PMID: 36574028
-
Trigeminal Neuralgia after Hyaluronic Acid and Botox Injection.Aesthetic Plast Surg. 2025 Mar;49(5):1622-1625. doi: 10.1007/s00266-024-03915-4. Epub 2024 Mar 1. Aesthetic Plast Surg. 2025. PMID: 38429530
-
A Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic Interventions.Aesthetic Plast Surg. 2024 Mar;48(6):1193-1209. doi: 10.1007/s00266-022-03207-9. Epub 2022 Dec 19. Aesthetic Plast Surg. 2024. PMID: 36536092 Free PMC article.
-
Elderberry Leaves with Antioxidant and Anti-Inflammatory Properties as a Valuable Plant Material for Wound Healing.Pharmaceuticals (Basel). 2024 May 10;17(5):618. doi: 10.3390/ph17050618. Pharmaceuticals (Basel). 2024. PMID: 38794188 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical